AI assistant
Sending…
Xbrane Biopharma — Major Shareholding Notification 2020
Jun 4, 2020
3128_iss_2020-06-04_ea3049ff-a6f4-4611-9e72-65449ac6b1c0.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Xbrane Biopharma AB
Holder
Serendipity Group AB
Instrument
| Instrument | Shares | |||
|---|---|---|---|---|
| Before the transaction | ||||
| Shares | 0 | |||
| Voting rights | 0 | |||
| Transaction | ||||
| Date | 01/06/2020 | |||
| Limit for number of shares 10 % | ||||
| Limit for number of votes | 10 % | |||
| After the transaction |
Quantity
| Shares | 2,819,967 |
|---|---|
| Directly held voting rights 2,819,967 | |
| Indirectly held voting rights 0 |
Percentage
| Directly held shares | 14.63474 % |
|---|---|
| Directly held voting rights 14.63474 % | |
| Indirectly held voting rights 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 14.63474 % | 2,819,967 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 14.63474 % | 2,819,967 |
| Group total holdings Voting rights 2,819,967 |
Percentage of voting rights 14.63474
Notes (other relevant informations according to law)
Orsak till flaggning: Flaggningen avser återleverans av utlånade aktier (2 255 974 stycken) i samband med nyemission i Xbrane Biopharma AB samt teckning och tilldelning av aktier i nämnda nyemission (563 993 stycken). Flaggningen är baserad på 19 268 998 utestående aktier i Xbrane Biopharma AB.
Published
04/06/2020 15:56
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xbrane Biopharma
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
AGM Information
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
May 5
Capital/Financing Update
2026
May 5
Capital/Financing Update
2026
Apr 30